The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.
J Infect Public Health
; 15(2): 228-240, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-35042059
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccines
/
COVID-19
Limits:
Humans
Language:
En
Journal:
J Infect Public Health
Journal subject:
DOENCAS TRANSMISSIVEIS
/
SAUDE PUBLICA
Year:
2022
Document type:
Article
Affiliation country:
India
Country of publication:
United kingdom